You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary

 

Online download statistics by month:

Online download statistics by month: January 2022 to November 2023

AbstractFullPdf
Jan 2022475490111
Feb 2022307309105
Mar 202218819181
Apr 202216617141
May 202215616258
Jun 202213413934
Jul 202213313953
Aug 202215515546
Sep 202213813968
Oct 202213718657
Nov 202211211328
Dec 202212012234
Jan 202310110238
Feb 202312913042
Mar 2023939352
Apr 2023727235
May 2023797928
Jun 202311211237
Jul 2023797936
Aug 202311411430
Sep 2023808034
Oct 2023848431
Nov 2023989827
Total326233591106